Investment Stage

Focus Areas

About Investor

Christopher Shen is a Partner at Novo Holdings Venture Investments based in California, United States, specializing in Medical Devices. He invests at the Series A stage with typical deal sizes between $5M and $15M. His responsibilities include evaluating advanced healthcare technologies, leading investment decisions, and supporting clinical and commercial scaling. He operates within a healthcare-focused venture platform with strong institutional backing. His role requires deep expertise in medical innovation and regulatory-driven industries. Overall, he is a senior investor focused on scaling medical device companies through growth-stage funding.